HPV vaccine: anger over decision not to extend NHS scheme to boys

Health bodies condemn panel's conclusion that more jabs against cancer-causing infection are unlikely to be cost-effective

A decision not to vaccinate boys against a cancer-causing sexually transmitted infection has been condemned by health bodies and campaigners.

The Joint Committee on Vaccination and Immunisation (JCVI), which has been reviewing the human papilloma virus (HPV) vaccination programme, concluded that it was "highly unlikely to be cost-effective" to extend the scheme to include adolescent boys as well as girls.